Brainsway Ltd Asset Resilience Ratio

Latest as of June 2026: 0.87%

Brainsway Ltd asset resilience ratio. Brainsway Ltd (BWAY) has an Asset Resilience Ratio of 0.87% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Brainsway Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

ILA1.06 Million
≈ $2.84K USD Cash + Short-term Investments

Total Assets

ILA121.97 Million
≈ $327.01K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Brainsway Ltd (2012–2025)

Asset resilience ratio of Brainsway Ltd from 2012 to 2025. This chart shows how Brainsway Ltd's Asset Resilience Ratio has changed over time. See BWAY free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Brainsway Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BWAY total asset value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ILA0.00 0%
Short-term Investments ILA1.06 Million 0.87%
Total Liquid Assets ILA1.06 Million 0.87%

Asset Resilience Insights

  • Limited Liquidity: Brainsway Ltd maintains only 0.87% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Brainsway Ltd Industry Peers by Asset Resilience Ratio

Compare Brainsway Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
GN Store Nord
CO:GN
Medical Devices -4.56%
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
Medical Devices 6.09%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
VIROMED MEDICAL NA O.N.
XETRA:VME
Medical Devices 0.03%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%

Brainsway Ltd Asset Resilience Ratio by Year (2012–2025)

Brainsway Ltd asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for Brainsway Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.27% ILA1.43 Million
≈ $3.84K
ILA112.94 Million
≈ $302.79K
--
2024-12-31 0.00% ILA0.00
≈ $0.00
ILA94.32 Million
≈ $252.86K
--
2023-12-31 56.32% ILA35.47 Million
≈ $95.08K
ILA62.97 Million
≈ $168.83K
+55.90pp
2022-12-31 0.42% ILA271.00K
≈ $726.54
ILA64.48 Million
≈ $172.86K
-52.96pp
2021-12-31 53.38% ILA40.43 Million
≈ $108.39K
ILA75.73 Million
≈ $203.03K
+52.73pp
2020-12-31 0.65% ILA221.00K
≈ $592.49
ILA34.01 Million
≈ $91.18K
+0.08pp
2019-12-31 0.57% ILA221.00K
≈ $592.49
ILA38.74 Million
≈ $103.85K
+0.14pp
2018-12-31 0.43% ILA101.00K
≈ $270.78
ILA23.60 Million
≈ $63.28K
+0.24pp
2017-12-31 0.18% ILA50.00K
≈ $134.05
ILA27.03 Million
≈ $72.47K
-2.75pp
2016-12-31 2.93% ILA585.00K
≈ $1.57K
ILA19.96 Million
≈ $53.52K
+0.30pp
2015-12-31 2.63% ILA585.00K
≈ $1.57K
ILA22.24 Million
≈ $59.63K
-1.56pp
2014-12-31 4.19% ILA1.08 Million
≈ $2.89K
ILA25.77 Million
≈ $69.09K
-3.98pp
2013-12-31 8.16% ILA1.46 Million
≈ $3.91K
ILA17.85 Million
≈ $47.85K
-37.63pp
2012-12-31 45.80% ILA4.89 Million
≈ $13.12K
ILA10.69 Million
≈ $28.65K
--
pp = percentage points

About Brainsway Ltd

TA:BWAY Israel Medical Devices
Market Cap
$394.54 Million
ILA147.16 Billion ILA
Market Cap Rank
#13128 Global
#140 in Israel
Share Price
ILA3656.00
Change (1 day)
+3.72%
52-Week Range
ILA2423.00 - ILA5074.00
All Time High
ILA5074.00
About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more